The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 12, 2023

Primary Completion Date

May 12, 2025

Study Completion Date

May 12, 2026

Conditions

Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic PhaseFatigueSleep Disturbance

Interventions

DEVICE

Motion watch

Actigraphy watch to be worn for 14 days

Trial Locations (1)

Imperial NHS Healthcare Trust, London

All Listed Sponsors

lead

Imperial College Healthcare NHS Trust

OTHER